PRODUCT DETAIL

Amlessa 2,85 mg/2,5 mg tablety

Code

8925C

MA number

58/0299/18-S

Product Form:

tbl 10x2,85 mg/2,5 mg (blis.OPA/Al/PVC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09B	ACE INHIBITORS, COMBINATIONS
C09BB	ACE inhibitors and calcium channel blockers
C09BB04	Perindopril and amlodipine

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	12.09.2018
SPC:	SPC_Amlessa_tbl_04_2024.pdf
PIL:	PIL_Amlessa_tbl_04_2024.pdf
Safety feature	Yes
Data update:	08.12.2023